The RDIF said that the "light vaccine" can be sent to foreign markets

Sputnik V Light is a one-component vaccine that will provide different levels of protection - up to 85%.

Basically, this vaccine can be directed to foreign markets, where there are strong epidemic foci, ”TASS quotes him.

He added that the fund covers the expenses of the Center.

Gamaleya for the necessary clinical trials of Sputnik V Light.

“We see a significant demand for this vaccine, precisely for this approach, from various foreign countries, while in Russia, of course, our flagship will be Sputnik V,” stressed Dmitriev.

As Russian President Vladimir Putin said earlier, specialists from the Gamaleya Center can create a "light vaccine" against coronavirus with one injection and a shorter period of antibody production.

Head of the Center.

Gamalei Alexander Gunzburg explained that such a drug allows you to offer some compromise between the duration of the vaccine drug and the need to quickly bring down the peak of the incidence.